Recent REPL News
- Replimune to Present at Two Upcoming Investor Conferences • GlobeNewswire Inc. • 03/02/2026 01:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/17/2026 01:28:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/03/2026 01:12:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/03/2026 01:05:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 01:00:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2025 10:11:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2025 10:10:07 PM
- Replimune to Present at the 44th Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 12/18/2025 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/04/2025 09:30:14 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/02/2025 09:11:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 09:31:07 PM
- Replimune Presents Late-Breaking Abstract and Additional Posters on RP1 at 40th Annual Meeting of the Society for the Immunotherapy of Cancer (SITC 2025) • GlobeNewswire Inc. • 11/07/2025 09:45:00 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/06/2025 09:20:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2025 01:20:39 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2025 01:07:55 PM
- Replimune Reports Fiscal Second Quarter 2026 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/06/2025 01:00:00 PM
- Replimune Shares Skyrocket After FDA Accepts Resubmitted BLA for Melanoma Therapy • IH Market News • 10/20/2025 12:11:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/20/2025 11:20:45 AM
- Replimune Announces FDA Acceptance of BLA Resubmission of RP1 for the Treatment of Advanced Melanoma • GlobeNewswire Inc. • 10/20/2025 11:00:00 AM
- Replimune Highlights Acral Melanoma Data for RP1 plus Nivolumab at the ESMO Congress 2025 • GlobeNewswire Inc. • 10/19/2025 12:00:00 PM
- Replimune Group, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before September 22, 2025 to Discuss Your Rights - REPL • PR Newswire (US) • 09/22/2025 12:45:00 PM
- Replimune Group, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - REPL • PR Newswire (US) • 09/22/2025 09:35:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 01:20:45 PM
The Crypto Company Acquires FRAME Blockchain's Technology, An "Interstate Highway" Liquidity Layer for Crypto Commerce • CRCW • Mar 26, 2026 12:28 PM
Resilient Energy Inc. Enters LOI Negtiations for Second Acquisition; First Acquisition Nears Closing • RENI • Mar 26, 2026 10:30 AM
Alliance Creative Group (ACGX) Releases 2025 Annual Financial and Disclosure Report • ACGX • Mar 26, 2026 8:30 AM
Isiah Enterprises Activates Scalable Materials Platform Targeting $900B+ Global Market Opportunity; Initiates Strategic Partner Alignment Phase • OWPC • Mar 25, 2026 9:07 AM
ECGI Signs Definitive $25 Million Agreement to Acquire RezyFi • ECGI • Mar 24, 2026 8:30 AM
Cannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction Client • BLOZF • Mar 19, 2026 12:45 PM
